Labetalol Hydrochloride Injection
Product Images NDC 72266-102

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 72266-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Labetalol 20ml Label

Labetalol 20ml Label
Labetalol Hydrochloride Injection is a medication that should only be given via intravenous injection using a multi-dose vial. Each mL of this medication contains 5mg of labetalol hydrochloride, as well as anhydrous dextrose, edetate disodium, citric acid monohydrate, and sodium hydroxide. This medication is stored within the temperature range of 20°C to 25°C (68°F to 77°F) to maintain its stability. It is distributed by a company located in Princeton, NJ and is manufactured in India. The medication comes with a package insert that should be consulted for standard adult dosage and administration.*
FDA Label Image

Labetalol 40ml Carton

Labetalol 40ml Carton
This is a description of Labetalol Hydrochloride Injection, which is intended for intravenous use only. It comes in a 40 mL multi-dose vial with a concentration of 200 mg/40 mL. Each mL of this injection contains 5 mg of labetalol hydrochloride USP, 45 mg of anhydrous dextrose, and other ingredients including preservatives. The package insert should be consulted for recommended dosage and route of administration. The product should be stored at a controlled room temperature of 20° to 25°C, protected from freezing and light, and should not be used after the expiration date. The product is distributed by Fosun Pharma USA Inc. in the USA and was made in India.*
FDA Label Image

Labetalol 40ml Label

Labetalol 40ml Label
This is a description of a medication called Labetalol Hydrochloride Injection, USP which is meant for intravenous injection only. The medication contains labetalol hydrochloride USP, anhydrous dextrose, edetate disodium, citric acid monohydrate, sodium hydroxide, methylparaben and propylparaben as preservatives. The medication is packaged in a 40 mL multi-dose vial and is made in India. The usual adult dosage and route of administration are provided in the package insert. The medication should be stored at 20°C to 25°C and protected from freezing and light. It is distributed by Fosun Pharma USA Inc. with a GTIN of 00372266103017. Though not explicitly mentioned, the lot number is likely printed on the packaging.*
FDA Label Image

Labetalol Structural Formula

FDA Label Image

Labetolol 20ml Carton

Labetolol 20ml Carton
Labetalol Hydrochloride Injection is a medication used for intravenous injection only, available in a 20 mL multi-dose vial with 100 mg/20 ml (5 mg/mL) concentration. This medication is manufactured by FOSUNPHARMA and contains labetalol hydrochloride USP, anhydrous dextrose, edetate disodium, citric acid monohydrate, sodium hydroxide, methylparaben, and propylparaben as preservatives. The medication is intended for adult use only and must be stored between 20° to 25°C (68°to 77°F). It must be protected from freezing and light and retained in the carton until the time of use. The medication is distributed by Fosun Pharma USA Inc, Princeton, NJ, and made in India. Package insert contains information about the usual adult dosage and administration route.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.